Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution Compared to DF289 Otic Solution and to DF277 Otic Solution in the Treatment of Acute Otitis Externa (AOE)

Trial Profile

A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution Compared to DF289 Otic Solution and to DF277 Otic Solution in the Treatment of Acute Otitis Externa (AOE)

Recruiting
Phase of Trial: Phase III

Latest Information Update: 25 Sep 2018

At a glance

  • Drugs Ciprofloxacin/fluocinolone acetonide (Primary) ; Ciprofloxacin; Fluocinolone acetonide
  • Indications Otitis externa
  • Focus Therapeutic Use
  • Sponsors SALVAT
  • Most Recent Events

    • 25 Sep 2018 Planned End Date changed from 1 Aug 2018 to 1 Sep 2018.
    • 25 Jul 2018 Planned End Date changed from 1 Dec 2017 to 1 Aug 2018.
    • 25 Jul 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Aug 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top